Condition: Myasthenia Gravis · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (\<) 18 years of age (globally) and 8 to \<18 years of age (for Unites Stated (US) sites only), the safety and tolerability of treatment with nipocalimab in children and adolescents and to evaluate the pharmacokinetics (PK) of nipocalimab in children and adolescents with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing, stable standard-of-care therapy.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Recruiting |
| Childrens Hospital Los Angeles | Los Angeles, California, United States | Completed |
| Lucile Packard Children's Hospital Stanford | Palo Alto, California, United States | Recruiting |
| UCSF Benioff Children's Hospital | San Francisco, California, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| University of South Florida Morsani Center for Advanced Healthcare | Tampa, Florida, United States | Recruiting |
| University of Kansas Medical Center | Lawrence, Kansas, United States | Completed |
| C.S. Mott Children's Hospital | Ann Arbor, Michigan, United States | Recruiting |
| Penn State Milton S Hershey Medical Ctr | Hershey, Pennsylvania, United States | Recruiting |
| Childrens Hospital Of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Terminated |
| Nagano Children's Hospital | Azumino-shi, Japan | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05265273